LONDON — The United Kingdom Health Security Agency (UKHSA) has confirmed that nine asymptomatic people who were exposed to a confirmed hantavirus case are scheduled to land in Britain on Sunday, marking the latest phase of the country’s public health response to the ongoing multi-location outbreak. All nine contacts, who are currently based on the UK overseas territories of Saint Helena and Ascension Island, will be moved immediately upon arrival to a dedicated isolation unit at Arrowe Park Hospital, a medical facility located just outside Liverpool in northwest England, according to the agency’s official statement.
This new intake of potential exposure cases comes as the UK already manages other people linked to the outbreak, which was first traced back to a cruise ship in April. A healthcare worker based on Ascension Island, who developed symptoms after close contact with a person showing hantavirus signs, has already been transported to the UK for ongoing medical care. UKHSA officials note that this patient will undergo additional diagnostic testing and comprehensive clinical evaluation at the Arrowe Park isolation unit on the same day the nine new contacts arrive.
The first group of people linked to the outbreak, roughly 20 former passengers from the cruise ship MV Hondius, were repatriated to the UK from the Canary Islands a week prior to the arrival of the new contacts. As of Saturday, eight of these 20 quarantined passengers have completed their initial hospital quarantine period and have been discharged to continue 45 more days of self-isolation at private residences, per an update from UKHSA.
Across the entire global outbreak, three people have so far died from hantavirus infection. Unlike the Covid-19 pandemic that swept the globe in recent years, no licensed vaccines or targeted antiviral therapies currently exist to prevent or treat hantavirus infection. Despite the lack of targeted interventions and reported deaths, public health officials have stressed that the current outbreak does not pose the same large-scale transmission risk as Covid-19, pushing back on widespread comparisons between the two pathogens in public discourse.